EVELO BIOSCIENCES INC (EVLO) Stock Analyst Earnings Estimates
NASDAQ:EVLO - Nasdaq - US2997342025 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A 335.19% | N/A 57.17% | ||||||||
| EBITDA YoY % growth | -12.53M | -26.7M -113.09% | -56.16M -110.34% | -84.6M -50.64% | -89.86M -6.22% | -113.17M -25.94% | -106.41M 5.97% | N/A 23.80% | N/A -6.42% | N/A -7.06% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -13.03M | -27.53M -111.28% | -58.1M -111.04% | -86.36M -48.64% | -91.89M -6.40% | -115.39M -25.57% | -108.47M 6.00% | N/A 34.27% | N/A 42.42% | N/A 5.71% | N/A -5.80% | N/A -3.61% | N/A 33.53% | N/A 100.00% | N/A | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | -2.66 2.69% | -2.41 9.40% | -12.51 -419.09% | -29.00 -131.81% | N/A 85.07% | N/A 47.47% | N/A 8.74% | N/A 74.94% | N/A 152.94% | N/A 418.52% | N/A | N/A |
All data in USD
| Q4 / 23 | Q1 / 24 | Q2 / 24 | Q3 / 24 | Q4 / 24 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.85 79.84% | -0.37 91.94% | -0.33 91.26% | -0.42 57.87% | -0.42 50.60% |
| Revenue Q2Q % growth | |||||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -16.014M 24.07% | -9.69M 61.08% | -8.16M 54.54% | -15.147M -45.78% | -15.198M 5.10% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2023 Q2Q % growth | -3.78 52.75% | -3.37 | -0.41 | -12.30% |
| Q1 2023 Q2Q % growth | -4.60 58.93% | -3.22 | -1.38 | -42.72% |
| Q4 2022 Q2Q % growth | -4.20 61.11% | -5.63 | 1.43 | 25.40% |
| Q3 2022 Q2Q % growth | -5.60 -788.89% | -6.83 | 1.23 | 18.01% |
| Q2 2022 Q2Q % growth | -8.00 -1,409.43% | -8.84 | 0.84 | 9.50% |
| Q1 2022 Q2Q % growth | -11.20 -1,936.36% | -11.87 | 0.67 | 5.67% |
| Q4 2021 Q2Q % growth | -10.80 -1,641.94% | -12.44 | 1.64 | 13.21% |
| Q3 2021 Q2Q % growth | -0.63 -40.00% | -0.55 | -0.08 | -14.38% |
| Q2 2021 Q2Q % growth | -0.53 15.87% | -0.55 | 0.02 | 4.07% |
| Q1 2021 Q2Q % growth | -0.55 22.54% | -0.52 | -0.03 | -6.61% |
| Q4 2020 Q2Q % growth | -0.62 11.43% | -0.54 | -0.08 | -15.23% |
| Q3 2020 Q2Q % growth | -0.45 32.84% | -0.51 | 0.06 | 12.20% |
| Q2 2020 Q2Q % growth | -0.63 3.08% | -0.80 | 0.17 | 20.81% |
| Q1 2020 Q2Q % growth | -0.71 -10.94% | -0.75 | 0.04 | 4.78% |
| Q4 2019 Q2Q % growth | -0.70 | -0.62 | -0.08 | -12.14% |
| Q3 2019 Q2Q % growth | -0.67 | -0.64 | -0.03 | -4.68% |
| Q2 2019 Q2Q % growth | -0.65 | -0.63 | -0.02 | -3.16% |
| Q1 2019 Q2Q % growth | -0.64 | -0.53 | -0.11 | -19.86% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -16.9% | 0% | 0% |
| Revenue | N/A | N/A | N/A | N/A |